Christophe Hilbert, senior manager of Access, Value, and Evidence Strategy, Europe at bluebird bio explores the problems of pricing and reimbursement for gene and cell therapies in Europe.
Ian Bolland is joined by Dr Anne Blackwood from Health Enterprise East. Following on from a previous discussion about equality and diversity in medtech, they delve into more about a potential culture change when it comes to making innovations stick p
EPM speaks to technology company Lifebit about its collaboration with pharmaceutical organisation Boehringer to report on infectious disease outbreaks.
Jay McHarg, CEO of AeroSafe Global, discusses the importance of a sustainable, eco-friendly supply chain, how it's critical for pharmaceutical companies and how it can play a role in delivering better outcomes for both patients and the environment.
John Norman, technical service representative for the Tooling and Tablets division at Natoli examines the importance of both dimensional and visual tool inspections and their direct relationship to final tablet quality.
Ray Chohan co-founder and vice president of new ventures at innovation intelligence expert Patsnap looks at technology’s ability to expedite the analysis of data in pharma and how it can help bring about new therapies for patients.
Ian Bolland is joined by Bernard Ross, CEO of Sky Medical to discuss keeping up the innovation momentum that has developed since the Coronavirus outbreak.
Advanced Workplace Associates founder Andrew Mawson and Chris Hood, director of Consulting, EMEA examine how pharmaceutical leaders can maximise the performance of any virtual or hybrid teams.
